Literature DB >> 22342471

Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk.

Alain H Litwin1, Bryce D Smith, Mari-Lynn Drainoni, Diane McKee, Allen L Gifford, Elisa Koppelman, Cindy L Christiansen, Cindy M Weinbaum, William N Southern.   

Abstract

BACKGROUND: An estimated 3.2 million persons are chronically infected with the hepatitis C virus (HCV) in the U.S. Effective treatment is available, but approximately 50% of patients are not aware that they are infected. Optimal testing strategies have not been described.
METHODS: The Hepatitis C Assessment and Testing Project (HepCAT) was a serial cross-sectional evaluation of two community-based interventions designed to increase HCV testing in urban primary care clinics in comparison with a baseline period. The first intervention (risk-based screener) prompted physicians to order HCV tests based on the presence of HCV-related risks. The second intervention (birth cohort) prompted physicians to order HCV tests on all patients born within a high-prevalence birth cohort (1945-1964). The study was conducted at three primary care clinics in the Bronx, New York.
RESULTS: Both interventions were associated with an increased proportion of patients tested for HCV from 6.0% at baseline to 13.1% during the risk-based screener period (P<0.001) and 9.9% during the birth cohort period (P<0.001).
CONCLUSIONS: Two simple clinical reminder interventions were associated with significantly increased HCV testing rates. Our findings suggest that HCV screening programs, using either a risk-based or birth cohort strategy, should be adopted in primary care settings so that HCV-infected patients may benefit from antiviral treatment.
Copyright © 2011 Editrice Gastroenterologica Italiana S.r.l. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22342471     DOI: 10.1016/j.dld.2011.12.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  42 in total

1.  Detecting Hepatitis B and C by Combined Public Health and Primary Care Birth Cohort Testing.

Authors:  Jeanne Heil; Christian J P A Hoebe; Jochen W L Cals; Henriëtte L G Ter Waarbeek; Inge H M van Loo; Nicole H T M Dukers-Muijrers
Journal:  Ann Fam Med       Date:  2018-01       Impact factor: 5.166

2.  Impact of an electronic health record alert in primary care on increasing hepatitis c screening and curative treatment for baby boomers.

Authors:  Monica A Konerman; Mary Thomson; Kristen Gray; Meghan Moore; Hetal Choxi; Elizabeth Seif; Anna S F Lok
Journal:  Hepatology       Date:  2017-09-14       Impact factor: 17.425

3.  Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study.

Authors:  Sabrina A Assoumou; Shayla Nolen; Liesl Hagan; Jianing Wang; Golnaz Eftekhari Yazdi; William W Thompson; Kenneth H Mayer; Jon Puro; Lin Zhu; Joshua A Salomon; Benjamin P Linas
Journal:  Am J Med       Date:  2020-06-27       Impact factor: 4.965

4.  Results of Hepatitis C Birth-Cohort Testing and Linkage to Care in Selected U.S. Sites, 2012-2014.

Authors:  Rajiv C Patel; Claudia Vellozzi; Bryce D Smith
Journal:  Public Health Rep       Date:  2016 May-Jun       Impact factor: 2.792

5.  No Differences in Achieving Hepatitis C Virus Care Milestones Between Patients Identified by Birth Cohort or Risk-Based Screening.

Authors:  Brianna L Norton; William N Southern; Meredith Steinman; Bryce D Smith; Joseph Deluca; Zachary Rosner; Alain H Litwin
Journal:  Clin Gastroenterol Hepatol       Date:  2016-04-19       Impact factor: 11.382

Review 6.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

7.  Implementation of Birth-Cohort Testing for Hepatitis C Virus.

Authors:  Danielle Liffmann Kruger; David B Rein; Natalie Kil; Cynthia Jordan; Kimberly A Brown; Anthony Yartel; Bryce D Smith
Journal:  Health Promot Pract       Date:  2016-08-19

8.  Primary Care Physician Perspectives on Hepatitis C Management in the Era of Direct-Acting Antiviral Therapy.

Authors:  Mary Thomson; Monica A Konerman; Hetal Choxi; Anna S F Lok
Journal:  Dig Dis Sci       Date:  2016-03-08       Impact factor: 3.199

9.  Recommendations for the management of hepatitis C virus infection among people who inject drugs.

Authors:  Jason Grebely; Geert Robaeys; Philip Bruggmann; Alessio Aghemo; Markus Backmund; Julie Bruneau; Jude Byrne; Olav Dalgard; Jordan J Feld; Margaret Hellard; Matthew Hickman; Achim Kautz; Alain Litwin; Andrew R Lloyd; Stefan Mauss; Maria Prins; Tracy Swan; Martin Schaefer; Lynn E Taylor; Gregory J Dore
Journal:  Int J Drug Policy       Date:  2015-07-17

10.  Disparities in hepatitis C testing in U.S. veterans born 1945-1965.

Authors:  Souvik Sarkar; Denise A Esserman; Melissa Skanderson; Forrest L Levin; Amy C Justice; Joseph K Lim
Journal:  J Hepatol       Date:  2016-04-27       Impact factor: 25.083

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.